Search Results - "Sociè, Gerard"
-
1
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Published in Haematologica (Roma) (01-08-2018)“…Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-risk or intermediate - acute myeloid leukemia. In patients…”
Get full text
Journal Article -
2
Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant
Published in British journal of haematology (01-05-2015)“…Summary This study analysed the outcome of 563 Aplastic Anaemia (AA) children aged 0–12 years reported to the Severe Aplastic Anaemia Working Party database of…”
Get full text
Journal Article -
3
CD34+ cell dose effects on clinical outcomes after T‐cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT)
Published in American journal of hematology (01-08-2020)“…Previous observations have reported controversial conclusions regarding cell dose and survival endpoints after allogeneic hematopoietic stem cell…”
Get full text
Journal Article -
4
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia
Published in American journal of hematology (01-10-2018)“…Busulfan plus cyclophosphamide (BuCy) is the traditional conditioning regimen for allogeneic stem cell transplant (allo‐SCT) for young, fit patients with acute…”
Get full text
Journal Article -
5
Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT
Published in Bone marrow transplantation (Basingstoke) (01-01-2020)“…The incidence, the clinical characteristics, and the outcome of Kaposi sarcoma (KS) in patients after hematopoietic stem cell transplantation (HSCT) were…”
Get full text
Journal Article -
6
Thiotepa‐busulfan‐fludarabine Compared to Treosulfan‐based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT
Published in HemaSphere (01-10-2023)“…We conducted a registry analysis including adult acute myeloid leukemia (AML) patients in remission who had received thiotepa, busulfan, and fludarabine (TBF)…”
Get full text
Journal Article -
7
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single‐lineage marrow failure: a pilot study and a survey from the EBMT WPSAA
Published in British journal of haematology (01-03-2010)“…Summary An alemtuzumab‐based experimental immunosuppressive treatment (IST) regimen was investigated in 35 patients with severe aplastic anaemia (SAA), pure…”
Get full text
Journal Article -
8
Treating chronic GVHD-induced fibrosis?
Published in Blood (29-03-2018)Get full text
Journal Article -
9
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel
Published in Bone marrow transplantation (Basingstoke) (01-06-2020)“…This collaborative initiative aimed to provide recommendations on the use of polyclonal antithymocyte globulin (ATG) or anti-T lymphocyte globulin (ATLG) for…”
Get full text
Journal Article -
10
Acute graft-versus-host disease: from the bench to the bedside
Published in Blood (12-11-2009)“…During the past decade, progress in basic immunology has been impressive. In parallel, whereas our understanding of the pathophysiology of acute…”
Get full text
Journal Article -
11
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation
Published in Blood (16-05-2019)“…Allogeneic hematopoietic stem cell transplantation is curative in myelofibrosis, and current prognostic scoring systems aim to select patients for…”
Get full text
Journal Article -
12
Pathogenesis of acute graft‐versus‐host disease: from intestinal microbiota alterations to donor T cell activation
Published in British journal of haematology (01-10-2016)“…Summary Acute graft‐versus‐host disease (aGVHD) is a major life‐threatening complication of allogeneic haematopoietic cell transplantation (allo‐HCT). Here we…”
Get full text
Journal Article -
13
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse
Published in Blood (15-09-2022)“…Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most effective treatment for selected patients with acute myeloid leukemia (AML) and…”
Get full text
Journal Article -
14
Milestones in acute GVHD pathophysiology
Published in Frontiers in immunology (05-12-2022)“…In the past 65 years, over 25 000 referenced articles have been published on graft-versus-host disease (GVHD). Although this included clinically orientated…”
Get full text
Journal Article -
15
Indole derivatives, microbiome and graft versus host disease
Published in Current opinion in immunology (01-06-2021)“…•Microbiota and their metabolites maintain immune homeostasis within the gut.•Aryl hydrocarbon receptor ligands, or indoles, modulate innate and adaptive…”
Get full text
Journal Article -
16
Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis
Published in Journal of clinical oncology (01-03-2012)“…Patients with acute myeloid leukemia (AML) and FLT3/internal tandem duplication (FLT3/ITD) have poor prognosis if treated with chemotherapy only. Whether this…”
Get full text
Journal Article -
17
Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia
Published in Haematologica (Roma) (01-02-2018)“…Few therapeutic options are available for patients with aplastic anemia who are ineligible for transplantation or refractory to immunosuppressive therapy…”
Get full text
Journal Article -
18
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
Published in Blood (07-11-2013)“…We analyzed the prognostic impact of donor and recipient cytomegalovirus (CMV) serostatus in 16 628 de novo acute leukemia patients after allogeneic stem cell…”
Get full text
Journal Article -
19
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Published in Blood cancer journal (New York) (03-03-2020)“…Following chemotherapy, secondary acute myeloid leukemia (sAML), occurring after antecedent hematologic diseases, previous chemotherapy or radiation, has an…”
Get full text
Journal Article -
20
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation
Published in American journal of hematology (01-09-2018)“…Patients with acute myeloid leukemia (AML) in morphological first complete remission (CR1) pre‐allogeneic hematopoietic cell transplantation (HCT) may have…”
Get full text
Journal Article